Moderna Pops On Fourth-Quarter Report, But Can It Overcome Recent FDA Setbacks?

Moderna Stock Pops On Fourth-Ouarter Report, But Can It Overcome Recent FDA Setbacks? | Investor's Business DailyBREAKING: [Core CPI Inflation Falls To 2.5%. Lowest Since 2021 --- Moderna (MRNA) stock popped Friday after the company reported better-than-expected fourth-quarter sales and reiterated its guidance for 10% sales growth in 2026. But the company was mum on the prospects for it to hit breakeven in 2028. Earlier this week, the Food and Drug Administration refused to review Moderna's experimental flu ...